Northpond Ventures

www.npv.vc

VCMatch tracks Northpond Ventures as an investor focused on Biotech, Medtech, and Pharma companies, Pre-Seed and Seed rounds, and United States, Cambridge, Ma, and San Francisco, Ca markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed

Focus Areas

Biotech, Medtech, Pharma

Geography

United States, Cambridge, MA, and San Francisco, CA

Investment Thesis

Northpond is a science-driven venture capital firm that seeks to find and build the next breakthroughs by partnering closely with academic investigators and entrepreneurial teams to translate laboratory discoveries into companies. Its approach combines direct investment with hands-on translational support (through Northpond Labs), mentorship, and institutional partnerships to move proof-of-concept science toward seed-stage companies and commercial impact for the benefit of humanity.

Is Northpond Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Northpond Ventures is most relevant for founders raising Pre-Seed and Seed rounds in Biotech, Medtech, Pharma, and AI/ML, especially across United States, Cambridge, MA, and San Francisco, CA.

Focus statement

Northpond focuses on early-stage, science- and technology-driven opportunities emerging from academic research—particularly in life sciences, diagnostics, biomanufacturing, synthetic biology, engineering-enabled therapeutics and platforms, and AI/software for treatment selection—by collaborating with institutions such as Harvard, MIT, Wyss Institute and Stanford.

Value Add

Northpond Labs: a dedicated research-and-development affiliate that "identifies, supports, funds, and engages early-stage science at leading academic institutions such as Harvard and MIT," enabling direct translational funding and lab partnerships.
Deep academic partnership model: formal programs and multi-year alliances (e.g., $12M Wyss alliance, MIT-Northpond Program) to fund translational projects, postdocs, mentorship and commercialization pathways.
Hands-on commercialization support: the firm "advises academic partners about the intricacies of the venture process" and runs co-creative, multi-faceted collaborations to prime discoveries for seed-stage funding.
Proven activity and scale: described as one of the most active lead biotech investors (Crunchbase/SVB citations) and reporting "over $2 billion in committed capital," indicating capacity to lead rounds and sustain translational programs.
Targeted programming to increase inclusion and translation: involvement in initiatives like the MIT Future Founders Prize to promote female entrepreneurship in biotech.